A new line of attack on deadly prostate cancers
Researchers have uncovered a potential drug target for stopping castration-resistant prostate tumors – the second leading cause of cancer death in the U.S. For decades, drug development for...
Category: Uncategorized
A new line of attack on deadly prostate cancers
Researchers have uncovered a potential drug target for stopping castration-resistant prostate tumors – the second leading cause of cancer death in the U.S. For decades, drug development for...
Knight Cancer signal achievements of 2017
Serving Oregonians. Delivering discoveries. Developing talented clinicians and scientists. Leading the way. Here's a look at the accomplishments of the people at the Knight Cancer Institute. They...
An evergreen ‘topping out’ for the Knight Cancer Research Building
(OHSU/Joe Rojas-Burke) Ironworkers placed the final steel beam onto the Knight Cancer Research Building on Monday. And in the "topping out" tradition, members of Ironworkers Local 29 signed the...
Enterprising cancer treatment ideas nurtured with pilot funds
Finding new treatment targets for aggressive prostate cancer, lymphoma and leukemia. Visualizing how breast tumors grow resistant to drug therapy. Using mobile phone sensors to track symptoms...
Two Knight Cancer scientists are among the world’s most highly cited
Knight Cancer Institute researchers Brian Druker, M.D., and Michael Heinrich, M.D., are among the "world's most influential scientific minds," according to the annual list produced by Thomson...